Since September 2012, she has served as Assistant Commissioner and Deputy Director of the FDA’s Office of International Programs (OIP). OIP leads FDA’s international activities and oversees the operation of FDA’s eleven regional and country offices. Prior to this position, she served as Acting Director of the Office of Scientific Investigations, and previously Director of the Division of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, FDA.